Efficient IBD mapping for Alzheimer's Disease and related brain imaging phenotypes
- Institution
- UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX
- Principal investigator
- Han Chen
- Funding
- $737K
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY/ABSTRACT Alzheimer’s Disease (AD) is a highly heritable complex human disease, but only a limited number of its genetic risk factors have been identified. In this project, we propose to leverage identical-by-descent (IBD) segments, which are expected to better tag haplotype effects and provide complementary genetic information to additively coded genotypes that are commonly used in genome-wide association studies, in the genetic association mapping for AD and related brain imaging endophenotypes. In Aim 1, we will develop the statistical and computational framework for efficient genetic association mapping using IBD segments in large samples. In Aim 2, we will apply IBD mapping to identify novel genomic regions associated with brain imaging endophenotypes from the UK Biobank. In Aim 3, we will replicate these associations in the Alzheimer’s Disease Sequencing Project (ADSP), develop and apply IBD mapping methods to AD, and combine association evidence from diverse populations in the UK Biobank and ADSP. Our novel tools and findings from this project will be made publicly available to facilitate novel discoveries that improve our understanding on the genetic architecture of AD and related brain imaging data.
Research team
- Han ChenPI
- Degui ZhiPI
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · University of Texas Hlth Sci Ctr Houston60
Receptor-Targeted Fluorescence-Guided Surgery in Pancreatic Neuroendocrine Tumors
Ali Azhdarinia · $485K · 2022–2028
- NIH · University of Texas Hlth Sci Ctr Houston51
Optimizing mRNA sequences with deep neural networks
Xiaobo Zhou · $351K · 2024–2028
- NIH · University of Texas Hlth Sci Ctr Houston48
Development of a precision medicine platform for circadian based therapeutics in pancreatic cancer
Faraz Bishehsari · $1.5M · 2024–2027